🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing
Updated 04 Sep 2026 · ClinicalTrials.gov

Clinical Trials in China

Every active and recruiting clinical study with an investigative site in China — searchable by condition, sponsor, phase and location. Refreshed daily from the ClinicalTrials.gov registry.

99
Recruiting now
178
Active studies
Starting soon Phase 1
Autoimmune Disease, Systemic Lupus Erythematosus, Systemic Sclerosis (SSc)
Shenzhen MagicRNA Biotechnology Co., Ltd · started 2026-12-31
Hefei
NCT07523282 on ClinicalTrials.gov ↗
Starting soon
Congenital Heart Disease (CHD), Congenital Heart Disease in Children
The Children's Hospital of Zhejiang University School of Medicine · started 2026-12-30
Hangzhou
NCT07574463 on ClinicalTrials.gov ↗
Starting soon
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Beijing Tongren Hospital · started 2026-10-31
Beijing
NCT07795658 on ClinicalTrials.gov ↗
Starting soon
Non-specific Low Back Pain, Pain Management
Beijing Tiantan Hospital · started 2026-09-01
Beijing
NCT07737158 on ClinicalTrials.gov ↗
Starting soon Phase 2
Nasopharyngeal Carcinoma (NPC)
Fudan University · started 2026-09-01
Shanghai
NCT07789158 on ClinicalTrials.gov ↗
Starting soon Phase 4
Hypertriglyceridemia Induced Acute Pancreatitis, Recurrent Acute Pancreatitis, Pancreatitis Relapsing, Hypertriglyceridemia
Peking Union Medical College Hospital · started 2026-09
Beijing
NCT07617155 on ClinicalTrials.gov ↗
Starting soon
Obstructive Sleep Apnea, Postoperative Analgesia, Oliceridine, Sufentanil
Peking University First Hospital · started 2026-09
Beijing
NCT07753785 on ClinicalTrials.gov ↗
Recruiting Phase 2
Short Bowel Syndrome, SBS
Chongqing Peg-Bio Biopharm Co., Ltd. · started 2026-08-30
Nanjing
NCT07704047 on ClinicalTrials.gov ↗
Recruiting
Non-small Cell Lung Cancer
AstraZeneca · started 2026-08-13
Beijing
NCT07542210 on ClinicalTrials.gov ↗
Recruiting Phase 3
Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC)
Hunan Province Tumor Hospital · started 2026-08-12
Changsha
NCT07251582 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Premature Ovarian Insufficiency
Shenzhen Wingor Biotechnology Co., Ltd. · started 2026-08-03
Beijing
NCT07775391 on ClinicalTrials.gov ↗
Starting soon Phase 2
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
West China Hospital · started 2026-08-01
Chengdu
NCT07649421 on ClinicalTrials.gov ↗
Starting soon Phase 3
Depressive Disorder, Major
Eli Lilly and Company · started 2026-08
Beijing · Chaohu · Jinan · Linfen · Shanghai · Suzhou
NCT07775300 on ClinicalTrials.gov ↗
Starting soon
Ulcerative Colitis (UC)
Tang-Du Hospital · started 2026-07-15
Xi’an
NCT07705126 on ClinicalTrials.gov ↗
Starting soon
A Target Trial Emulation Study, Donor Age, ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
The First Affiliated Hospital of Soochow University · started 2026-07-15
Suzhou
NCT07666568 on ClinicalTrials.gov ↗
By invitation
Sleep, Neurology
The First Hospital of Jilin University · started 2026-07-04
Changchun
NCT07374393 on ClinicalTrials.gov ↗
By invitation
Non-surgical Management;dMMR/MSI-H Gastric Cancer;Neoadjuvant Immunotherapy
Yong Zhou · started 2026-07-01
Chengdu
NCT07646574 on ClinicalTrials.gov ↗
Recruiting Phase 2
Head and Neck Cancer
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University · started 2026-07-01
Shanghai
NCT07662746 on ClinicalTrials.gov ↗
Starting soon Phase 2
Chronic Kidney Disease
Shenzhen Salubris Pharmaceuticals Co., Ltd. · started 2026-06-15
Shenzhen · Nanjing
NCT07647133 on ClinicalTrials.gov ↗
Starting soon Phase 2
Primary Aldosteronism
Shenzhen Salubris Pharmaceuticals Co., Ltd. · started 2026-06-12
Shanghai
NCT07646535 on ClinicalTrials.gov ↗
Starting soon
ACT, Perinatal Loss, Mental Health
Second Xiangya Hospital of Central South University · started 2026-06-01
Changsha
NCT07538011 on ClinicalTrials.gov ↗
Starting soon Phase 2
Metastatic Colorectal Cancer (CRC)
Sun Yat-sen University · started 2026-06-01
Guangzhou
NCT07621497 on ClinicalTrials.gov ↗
Recruiting
Acute Ischemic Stroke From Large Vessel Occlusion
Beijing Tiantan Hospital · started 2026-06
Beijing
NCT07626450 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Respiratory Syncytial Virus Infections
Ab&B Bio-tech Co., Ltd.JS · started 2026-05-14
Zigong
NCT07582796 on ClinicalTrials.gov ↗
Active Phase 1
Healthy
Suzhou Zelgen Biopharmaceuticals Co.,Ltd · started 2026-05-12
Changsha
NCT07565597 on ClinicalTrials.gov ↗
Recruiting Phase 2
Non-Small Cell Lung Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. · started 2026-04-29
Jinan
NCT07489716 on ClinicalTrials.gov ↗
Recruiting
Paroxysmal Atrial Fibrillation (PAF)
Abbott Medical Devices · started 2026-04-02
Jinan · Chengdu · Hangzhou · Ningbo · Beijing
NCT07421076 on ClinicalTrials.gov ↗
Recruiting Phase 1
Refractory/Recurrent Peripheral T-cell Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine · started 2026-04-01
Hangzhou
NCT07164560 on ClinicalTrials.gov ↗
Recruiting Phase 1
Solid Tumor, Colorectal Cancer, Non-small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. · started 2026-03-31
Tianjin
NCT07589205 on ClinicalTrials.gov ↗
Starting soon Phase 2
Muscle Invasive Bladder Cancer (MIBC)
chenxu · started 2026-03-26
Guangzhou
NCT07474064 on ClinicalTrials.gov ↗
Recruiting Phase 2
Immunoglobulin A Nephropathy (IgAN)
Novartis Pharmaceuticals · started 2026-03-26
Beijing · Shanghai
NCT07146906 on ClinicalTrials.gov ↗
Recruiting Phase 2
Seasonal Allergic Rhinitis
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. · started 2026-03-19
Beijing · Chongqing · Baoding · Cangzhou · Langfang · Shijiazhuang
NCT07398859 on ClinicalTrials.gov ↗
Recruiting Phase 2
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University · started 2026-03-12
Dongguan · Guangzhou · Shenzhen · Zhanjiang
NCT07362979 on ClinicalTrials.gov ↗
By invitation Phase 1/Phase 2
Epithelial Cancer Patients
Suzhou Immunofoco Biotechnology Co., Ltd · started 2026-03-05
Beijing
NCT07644403 on ClinicalTrials.gov ↗
Recruiting Phase 2
Immune Thrombocytopenia, Treatment
Institute of Hematology & Blood Diseases Hospital, China · started 2026-03
Tianjin
NCT07362238 on ClinicalTrials.gov ↗
Starting soon
Clinical Implementation, Standardized Tube Feeding Care, Enteral Nutrition
Children's Hospital of Fudan University · started 2026-03
Shanghai
NCT07441746 on ClinicalTrials.gov ↗
Starting soon Phase 4
ACS (Acute Coronary Syndrome), SGLT2 Inhibitors
Shenyang Northern Hospital · started 2026-02-25
Shenyang
NCT07351643 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Immunoglobulin A Nephropathy
Beijing Mabworks Biotech Co., Ltd. · started 2026-02-05
Beijing
NCT07375758 on ClinicalTrials.gov ↗
Recruiting Phase 2
Prediabetes, Insulin Resistance, Overweight/Obesity
Hudson Biotech · started 2026-02-02
Shenzhen
NCT07505745 on ClinicalTrials.gov ↗
Starting soon Phase 3
Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences · started 2026-02-01
Beijing
NCT07385365 on ClinicalTrials.gov ↗
Starting soon
Ischemic Stroke or High-risk TIA (ABCD² ≥ 4)
Beijing Tiantan Hospital · started 2026-02-01
Beijing
NCT07341958 on ClinicalTrials.gov ↗
Recruiting Phase 3
Hepatocellular Carcinoma, Adjuvant, Transarterial Chemoembolization
Guangxi Medical University · started 2026-02-01
Nanning
NCT07417397 on ClinicalTrials.gov ↗
Recruiting
Peripheral T Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · started 2026-01-20
Shanghai
NCT07353840 on ClinicalTrials.gov ↗
Recruiting
Robotic Surgical Procedures, Airway Extubation, Operating Rooms, Anesthesia Recovery Period
Peking University First Hospital · started 2026-01-12
Beijing
NCT07332806 on ClinicalTrials.gov ↗
Active
Breast Cancer (Triple Negative Breast Cancer (TNBC)), Breast Cancer
Xijing Hospital · started 2026-01-01
Xi'an
NCT07498400 on ClinicalTrials.gov ↗
Recruiting
Parkinson Disease, Insomnia
Jiangsu Province Nanjing Brain Hospital · started 2026-01-01
Nanjing
NCT07323121 on ClinicalTrials.gov ↗
Recruiting
Adhesive Capsulitis
Second Affiliated Hospital, Zhejiang University, School of Medicine · started 2026-01-01
Hangzhou
NCT06041282 on ClinicalTrials.gov ↗
Active Phase 2
Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences · started 2026-01-01
Beijing
NCT07480850 on ClinicalTrials.gov ↗
Recruiting
Hematoma Brain, Large Basal Ganglia Hemorrhage
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · started 2025-12-20
Nanjing
NCT06484374 on ClinicalTrials.gov ↗
Recruiting Phase 1
Influenza
Shanghai Institute Of Biological Products · started 2025-12-16
Wuhan
NCT07302256 on ClinicalTrials.gov ↗
Starting soon Phase 2
Pancreatic Cancer, Adult
The First Affiliated Hospital with Nanjing Medical University · started 2025-12-10
Nanjing · Beijing
NCT07277452 on ClinicalTrials.gov ↗
Starting soon Phase 2
Paroxysmal Nocturnal Hemoglobinuria
Longbio Pharma · started 2025-12-05
Nanjing
NCT07266155 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Advanced Solid Tumors
Grit Biotechnology · started 2025-11-01
Shanghai · Chengdu
NCT06144671 on ClinicalTrials.gov ↗
Active Phase 2
Arthritis, Rheumatoid
Merck Sharp & Dohme LLC · started 2025-10-08
Beijing · Xiamen · Guangzhou · Xinxiang · Pingxiang · Linfen
NCT07176390 on ClinicalTrials.gov ↗
Recruiting
Digestive System Malignancies
Tianjin Medical University Cancer Institute and Hospital · started 2025-10-01
Tianjin
NCT07263620 on ClinicalTrials.gov ↗
Recruiting Phase 2
Ulcerative Colitis
Genentech, Inc. · started 2025-09-29
Fuzhou · Xiamen · Guangzhou · Huizhou · Zhengzhou · Wuhan
NCT06979336 on ClinicalTrials.gov ↗
Recruiting
Chronic Bronchitis, COPD (Chronic Obstructive Pulmonary Disease)
Suzhou Hengruihongyuan Medical Technology Co. LTD · started 2025-09-01
Hefei · Beijing · Changzhou · Suzhou · Wuxi · Xuzhou
NCT07068438 on ClinicalTrials.gov ↗
Starting soon Phase 2
Advanced Intrahepatic Cholangiocarcinoma
Fudan University · started 2025-09-01
Shanghai
NCT07147088 on ClinicalTrials.gov ↗
Starting soon Phase 2
Hepatocellular Carcinoma Non-resectable
Song Peng · started 2025-09
Shenzhen
NCT07192848 on ClinicalTrials.gov ↗
Starting soon Phase 2
EGFR Mutant NSCLC and Platinum Resistant Ovarian Cancer
Innovent Biologics (Suzhou) Co. Ltd. · started 2025-08-31
Wuhan
NCT07124793 on ClinicalTrials.gov ↗
Recruiting
Insomnia Chronic, Cancer Caregivers
The University of Hong Kong · started 2025-08-11
Shanghai
NCT07089797 on ClinicalTrials.gov ↗
Recruiting
Cirrhosis, Decompensation, Transjugular Intrahepatic Portosystemic Shunt (TIPS), Survival Analysis
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · started 2025-08-01
Changsha · Fuzhou · Huanggang · Jingzhou · Nanchang · Nanjing
NCT07172035 on ClinicalTrials.gov ↗
Recruiting Phase 2
Prolonged Cytopenia Following CAR-T Therapy
Institute of Hematology & Blood Diseases Hospital, China · started 2025-08
Tianjin
NCT07127289 on ClinicalTrials.gov ↗
By invitation
Hypertriglyceridemia, Carotid Atherosclerotic Plaques
Junbo Ge · started 2025-07-01
Hefei · Suzhou · Shanghai
NCT07050134 on ClinicalTrials.gov ↗
Starting soon
Intrathoracic Lymphadenopathy
Shanghai Chest Hospital · started 2025-07-01
Shanghai
NCT07047417 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Inoperable Locally Advanced HER2-Negative Breast Cancer, Metastatic HER2-Negative Breast Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd · started 2025-06-01
Shanghai
NCT06942234 on ClinicalTrials.gov ↗
Active
End-Stage Renal Disease (ESRD), Maintenance Hemodialysis (MHD)
The First People's Hospital of Yunnan · started 2025-06-01
Kunming
NCT07303179 on ClinicalTrials.gov ↗
Starting soon Phase 3
Transplant-Related Disorder, Hepatitis B Virus Infection, Vaccine Reaction
Institute of Hematology & Blood Diseases Hospital, China · started 2025-06-01
Tianjin
NCT06888479 on ClinicalTrials.gov ↗
Starting soon Phase 4
Septic Shock, Vascular Dysfunction, Arterial Stiffness, Carotid Artery Elasticity Alterations
First Affiliated Hospital of Wannan Medical College · started 2025-04-15
Wuhu
NCT06915506 on ClinicalTrials.gov ↗
Active Phase 1
Hepatocellular Carcinoma (HCC), Unresectable Hepatocellular Cancer
Beijing Gene Key Life Technology Co., Ltd · started 2025-04-03
Beijing · Taiyuan
NCT07713290 on ClinicalTrials.gov ↗
Recruiting
Fragility Fractures
The Fourth Affiliated Hospital of Zhejiang University School of Medicine · started 2025-04-01
Yiwu
NCT06975254 on ClinicalTrials.gov ↗
Recruiting
Diminished Ovarian Reserve, IVF Outcomes
Peking University Third Hospital · started 2025-03-17
Beijing · Shijiazhuang · Yinchuan · Xi’an · Shenzhen
NCT06794047 on ClinicalTrials.gov ↗
Starting soon Phase 2
Primary Sjögren's Syndrome (pSS)
Peking University People's Hospital · started 2025-03-10
Beijing
NCT06862284 on ClinicalTrials.gov ↗
Recruiting
Ischemic Stroke, Transient Ischemic Attack (TIA)
Beijing Tiantan Hospital · started 2025-03-03
Beijing · Shihezi
NCT06783049 on ClinicalTrials.gov ↗
By invitation
Pancreatic Ductal Adenocarcinoma (PDAC)
RenJi Hospital · started 2025-03-02
Shanghai
NCT07373691 on ClinicalTrials.gov ↗
Recruiting
Hepatocellular Cancer (HCC)
Zhongshan People's Hospital, Guangdong, China · started 2025-03-01
Zhongshan
NCT07010198 on ClinicalTrials.gov ↗
Starting soon
Lung Nodule
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · started 2025-03-01
Wuhan
NCT06831617 on ClinicalTrials.gov ↗
Recruiting
Elderly (People Aged 65 or More), Home Environment Related Disease
Peking University Third Hospital · started 2025-03-01
Beijing
NCT06962696 on ClinicalTrials.gov ↗
Recruiting
Ventricular Tachycardia (VT), Ventricular Fibrillation
Medtronic Cardiac Rhythm and Heart Failure · started 2025-02-26
Wenzhou · Shanghai
NCT06745778 on ClinicalTrials.gov ↗
Recruiting Phase 3
Breast Cancer Stage IV, Triple -Negative Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · started 2025-02-21
Guangzhou · Guiyang · Wuhan · Yichang · Changsha · Yongzhou
NCT06889688 on ClinicalTrials.gov ↗
Starting soon EARLY_Phase 1
Synucleinopathies
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · started 2025-02-17
Wuhan
NCT06827821 on ClinicalTrials.gov ↗
Starting soon
Plaque Psoriasis, Psoriatic Arthritis, Scalp Psoriasis, Nail Psoriasis
Chongqing Genrix Biopharmaceutical Co., Ltd · started 2025-01-30
Hunan
NCT06802848 on ClinicalTrials.gov ↗
Recruiting Phase 2
NSCLC (Advanced Non-small Cell Lung Cancer), EGFR Mutation Positive Advanced Non Small Cell Lung Cancer
Fudan University · started 2025-01-15
Shanghai
NCT06775743 on ClinicalTrials.gov ↗
Recruiting Phase 1
Healthy Participants
Chengdu Brilliant Pharmaceutical Co., Ltd. · started 2025-01-10
Beijing
NCT06760455 on ClinicalTrials.gov ↗
Recruiting
Ovarian Cancer (OvCa)
Xiangya Hospital of Central South University · started 2025-01-01
Changsha
NCT06760923 on ClinicalTrials.gov ↗
By invitation
Respiratory Diseases, Artificial Intelligence (AI), Randomized Controlled Trial
The First Affiliated Hospital of Guangzhou Medical University · started 2025-01-01
Guangzhou
NCT06931782 on ClinicalTrials.gov ↗
Recruiting Phase 3
Moderate to Severe Atopic Dermatitis
Jiangsu vcare pharmaceutical technology co., LTD · started 2024-12-30
Nanjing
NCT06723080 on ClinicalTrials.gov ↗
Recruiting
Papillary Thyroid Cancer
Chinese PLA General Hospital · started 2024-12-10
Beijing
NCT06733740 on ClinicalTrials.gov ↗
Active Phase 2
Chronic Hepatitis B
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · started 2024-12-04
Chongqing · Guangzhou · Shenzhen · Liuzhou · Wuhan · Changsha
NCT06706310 on ClinicalTrials.gov ↗
Recruiting
Breast Cancer, Proton Therapy, Intensity Modulated Radiation Therapy, Efficacy and Safety
Ruijin Hospital · started 2024-12-01
Shanghai
NCT06826885 on ClinicalTrials.gov ↗
Recruiting
Gastric Cancer, Gastroesophageal Junction Cancer
Southwest Hospital, China · started 2024-12-01
Chongqing
NCT06760858 on ClinicalTrials.gov ↗
Recruiting Phase 2
Gastric Cancers
The First Affiliated Hospital with Nanjing Medical University · started 2024-11-14
Nanjing
NCT06895447 on ClinicalTrials.gov ↗
Recruiting EARLY_Phase 1
Intrahepatic Cholangiocarcinoma
Shanghai Changzheng Hospital · started 2024-11-07
Shanghai
NCT06583993 on ClinicalTrials.gov ↗
Starting soon
Sepsis, MODS, Shock
Ruijin Hospital · started 2024-11-01
Shanghai
NCT06634732 on ClinicalTrials.gov ↗
Recruiting
Cardiovascular System
Fudan University · started 2024-10-16
Shanghai
NCT06652425 on ClinicalTrials.gov ↗
Starting soon
Coronary Artery Disease
Shanghai NewMed Medical Co., Ltd. · started 2024-10-14
Jilin City · Chengdu · Zhengzhou · Wuhan · Changsha · Shenyang
NCT06639321 on ClinicalTrials.gov ↗
Recruiting Phase 2
Diffuse Cutaneous Systemic Sclerosis
Novartis Pharmaceuticals · started 2024-10-09
Nanning · Zhengzhou · Changchun · Chengdu · Ningbo · Beijing
NCT06470048 on ClinicalTrials.gov ↗
Recruiting
Health Communication
The University of Hong Kong · started 2024-10-01
NCT05691790 on ClinicalTrials.gov ↗
Active Phase 3
Breast Cancer
AstraZeneca · started 2024-09-26
Baoding · Beijing · Bengbu · Changchun · Changsha · Chengdu
NCT06635447 on ClinicalTrials.gov ↗
Active Phase 3
Moderately to Severely Active Ulcerative Colitis
Hoffmann-La Roche · started 2024-09-17
Beijing · Binzhou · Changchun · Chengdu · Fuzhou · Guangzhou
NCT06589986 on ClinicalTrials.gov ↗
Recruiting EARLY_Phase 1
Solid Tumor
Yi Zhang · started 2024-08-18
Zhengzhou
NCT06515626 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Keloid
Peking Union Medical College Hospital · started 2024-08-01
Beijing
NCT07660406 on ClinicalTrials.gov ↗
Recruiting Phase 2
Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes, Minimal Residual Disease
Beijing 302 Hospital · started 2024-07-18
Beijing
NCT06536959 on ClinicalTrials.gov ↗
Active Phase 2
Peripheral T Cell Lymphoma
The First Hospital of Jilin University · started 2024-06-30
Changchun
NCT06550336 on ClinicalTrials.gov ↗
Recruiting Phase 2
De-escalated Radiotherapy; Head and Neck Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · started 2024-05-01
Guangzhou
NCT06353685 on ClinicalTrials.gov ↗
Recruiting Phase 4
Sarcopenia in Elderly
Prince of Wales Hospital, Shatin, Hong Kong · started 2024-04-09
Hong Kong
NCT06643780 on ClinicalTrials.gov ↗
Recruiting
Lung Cancer Metastatic, Surgical Resection
Fudan University · started 2024-04-01
Shanghai
NCT06547710 on ClinicalTrials.gov ↗
Recruiting Phase 4
ACS - Acute Coronary Syndrome, CYP2C19 Polymorphism
Zunyi Medical College · started 2024-04-01
Zunyi
NCT06283888 on ClinicalTrials.gov ↗
Recruiting Phase 2
Syringomyelia, Thalidomide
Xuanwu Hospital, Beijing · started 2024-02
Beijing
NCT06268093 on ClinicalTrials.gov ↗
Active
Iddvt, Pulmonary Embolism (PE)
Ruijin Hospital · started 2024-01-01
Shanghai
NCT06596941 on ClinicalTrials.gov ↗
Recruiting
PARKINSON DISEASE (Disorder)
Fujian Medical University Union Hospital · started 2024-01-01
Fuzhou
NCT07679256 on ClinicalTrials.gov ↗
Recruiting
Adolescent Idiopathic Scoliosis
The First Affiliated Hospital of Zhejiang Chinese Medical University · started 2024-01-01
Hangzhou
NCT06758115 on ClinicalTrials.gov ↗
Active Phase 2
Early Childhood Caries
The University of Hong Kong · started 2024-01-01
Hong Kong
NCT06241261 on ClinicalTrials.gov ↗
Recruiting EARLY_Phase 1
Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory
Peking University People's Hospital · started 2023-12-30
Beijing
NCT06201247 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
B-cell Acute Lymphoblastic Leukemia (B-ALL)
AstraZeneca · started 2023-12-29
Changsha · Chengdu · Guangzhou · Hangzhou · Nanjing · Suzhou
NCT06137118 on ClinicalTrials.gov ↗
Recruiting Phase 2
NSCLC, Breast Cancer, HNSCC, Locally Advanced or Metastatic Solid Tumors
MediLink Therapeutics (Suzhou) Co., Ltd. · started 2023-12-15
Hefei · Beijing · Chongqing · Fuzhou · Guangzhou · Meizhou
NCT06107686 on ClinicalTrials.gov ↗
Recruiting Phase 3
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Merck Sharp & Dohme LLC · started 2023-12-13
Hefei · Beijing · Chongqing · Guangzhou · Liuzhou · Nanning
NCT06136559 on ClinicalTrials.gov ↗
Active
Valvular Heart Disease, Heart Murmurs, Cardiovascular Abnormalities
Wong Chun Ka · started 2023-12-01
Hong Kong
NCT06070298 on ClinicalTrials.gov ↗
Recruiting
Sleep Disturbance
Chinese University of Hong Kong · started 2023-12-01
Hong Kong
NCT06156293 on ClinicalTrials.gov ↗
Recruiting
Angle-closure Glaucoma, Minimally Invasive Glaucoma Surgery, Goniosynechialysis, Goniotomy
Zhongshan Ophthalmic Center, Sun Yat-sen University · started 2023-12-01
Guangzhou
NCT06492538 on ClinicalTrials.gov ↗
Active Phase 3
Ulcerative Colitis
Merck Sharp & Dohme LLC · started 2023-10-25
Hefei · Beijing · Chongqing · Fuzhou · Xiamen · Dongguan
NCT06052059 on ClinicalTrials.gov ↗
Starting soon Phase 2
Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · started 2023-10-20
Wuhan
NCT05993858 on ClinicalTrials.gov ↗
Recruiting
Autologous Epidermal Cell Transplantation
Yicheng Ma · started 2023-10-01
Shanghai
NCT05882110 on ClinicalTrials.gov ↗
Recruiting
Intratumoral Injection, Cancer
Wuxi People's Hospital · started 2023-09-01
Wuxi
NCT06430515 on ClinicalTrials.gov ↗
Recruiting
AIDS, Hepatitis B
Guangzhou 8th People's Hospital · started 2023-08-02
Guangzhou
NCT05988879 on ClinicalTrials.gov ↗
Recruiting
Preeclampsia, Maternal Deaths
The Third Affiliated Hospital of Guangzhou Medical University · started 2023-08-01
Guangzhou
NCT06383858 on ClinicalTrials.gov ↗
Recruiting
Prostate Cancer, Prostate Disease
The First Affiliated Hospital with Nanjing Medical University · started 2023-08-01
Nanjing
NCT06636747 on ClinicalTrials.gov ↗
Recruiting Phase 3
Generalized Anxiety Disorder
Beijing Union Pharmaceutical Factory Ltd · started 2023-07-24
Beijing
NCT06243614 on ClinicalTrials.gov ↗
Recruiting Phase 3
Advanced Gastroenteropancreatic Neuroendocrine Tumor
Jiangsu HengRui Medicine Co., Ltd. · started 2023-07-06
Shanghai · Tianjin
NCT05884255 on ClinicalTrials.gov ↗
Recruiting Phase 2
Neuroblastoma
Sun Yat-Sen University Cancer Center · started 2023-06-19
Guangzhou
NCT06013618 on ClinicalTrials.gov ↗
Active Phase 2
Endometrial Cancer, Endometrial Adenocarcinoma
Sun Yat-sen University · started 2023-05-08
Guangzhou
NCT05824481 on ClinicalTrials.gov ↗
Recruiting Phase 2
Colorectal Liver Metastasis (CRLM)
Tongji Hospital · started 2023-05-01
Wuhan
NCT06988852 on ClinicalTrials.gov ↗
Recruiting
Heart Failure
First Affiliated Hospital Xi'an Jiaotong University · started 2023-04-23
Xi'an
NCT05775432 on ClinicalTrials.gov ↗
Active Phase 1/Phase 2
Squamous Cell Carcinoma of Head and Neck
Sichuan Baili Pharmaceutical Co., Ltd. · started 2023-02-10
Shanghai
NCT05668858 on ClinicalTrials.gov ↗
Recruiting Phase 2
Adenocarcinoma of Small Intestine, Appendix Carcinoma, Metastatic
Sun Yat-sen University · started 2023-02-01
Guangzhou
NCT05472948 on ClinicalTrials.gov ↗
Active
Chronic Obstructive Pulmonary Disease, Lung Diseases, Obstructive
Shanghai University of Traditional Chinese Medicine · started 2023-01-03
Shanghai
NCT05940480 on ClinicalTrials.gov ↗
Active
Major Cardiovascular Event, Established Atherosclerotic Cardiovascular Disease
Amgen · started 2022-12-19
Beijing · Chongqing · Dongguan · Foshan · Guangzhou · Huizhou
NCT06295679 on ClinicalTrials.gov ↗
Recruiting Phase 3
Esophageal Squamous Cell Carcinoma, Oligometastatic Disease, Radiotherapy
Fudan University · started 2022-09-27
Shanghai
NCT06190782 on ClinicalTrials.gov ↗
Recruiting
Primary Aldosteronism
Second Affiliated Hospital of Nanchang University · started 2022-09-01
Nanchang
NCT05501080 on ClinicalTrials.gov ↗
Recruiting EARLY_Phase 1
Breast Cancer, Prostate Cancer, Brain Tumor, PET/CT Imaging
Peking Union Medical College Hospital · started 2022-08-16
Beijing
NCT05549024 on ClinicalTrials.gov ↗
By invitation
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital with Nanjing Medical University · started 2022-07-30
Nanjing
NCT06048926 on ClinicalTrials.gov ↗
Recruiting Phase 2
Her-2 Negative Breast Cancer, HRR Gene Mutation
Ying Lin · started 2022-05-06
Guangzhou
NCT05761470 on ClinicalTrials.gov ↗
Active Phase 4
Hepatitis B, Chronic
Jiangsu Hansoh Pharmaceutical Co., Ltd. · started 2022-03-10
Guangzhou
NCT06743438 on ClinicalTrials.gov ↗
Recruiting Phase 4
Butylphthalide, Cardiac Arrest, Neuroprotective Drugs
Tang Ziren · started 2022-01-01
Beijing
NCT06572085 on ClinicalTrials.gov ↗
Active
Methamphetamine Use Disorder
Shanghai Mental Health Center · started 2021-11-21
Beijing · Wuhan · Nanjing · Suzhou · Deyang
NCT06288997 on ClinicalTrials.gov ↗
Starting soon
Carbon Monoxide Poisoning
The First Hospital of Jilin University · started 2021-08-01
Changchun
NCT04925297 on ClinicalTrials.gov ↗
Active Phase 3
Peripheral T Cell Lymphoma
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · started 2021-04-13
Guangzhou
NCT04668690 on ClinicalTrials.gov ↗
Recruiting Phase 4
Hypertension, Blood Pressure, Drug Use
Yan Li · started 2021-01-28
Shanghai
NCT05089448 on ClinicalTrials.gov ↗
Recruiting
Cervical Cancer
Chongqing University Cancer Hospital · started 2021-01-11
Chongqing
NCT04555226 on ClinicalTrials.gov ↗
Recruiting
Multiple Myeloma, Acute Myeloid Leukemia, Hemophilia, Hemophilia A
Institute of Hematology & Blood Diseases Hospital, China · started 2020-12-01
Tianjin
NCT04645199 on ClinicalTrials.gov ↗
Recruiting
Childhood Leukemia
Chinese University of Hong Kong · started 2020-07-01
Hong Kong
NCT04478006 on ClinicalTrials.gov ↗
By invitation Phase 4
Analgesia, Patient-Controlled
West China Hospital · started 2018-12-01
Chengdu
NCT03685188 on ClinicalTrials.gov ↗
Active
Renal Tumors
Tianjin Medical University Second Hospital · started 2018-01-01
Tianjin
NCT06954571 on ClinicalTrials.gov ↗
Active Phase 3
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
BeiGene · started 2017-10-31
Hefei · Beijing · Chongqing · Fuzhou · Quanzhou · Guangzhou
NCT03336333 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Non-small Cell Lung Cancer, Small Cell Lung Cancer, Pancreas Cancer, Hepatocellular Carcinoma
Shanghai Public Health Clinical Center · started 2017-03-01
Shanghai
NCT03093688 on ClinicalTrials.gov ↗
Recruiting
Cardiogenic Shock, Cardiac Arrest, Heart Failure, Acute Respiratory Distress Syndrome
Beijing Anzhen Hospital · started 2017-01-01
Beijing
NCT04158479 on ClinicalTrials.gov ↗
Active Phase 1/Phase 2
Acute Lymphoblastic Leukemia With Failed Remission
The First Affiliated Hospital of Soochow University · started 2015-12-01
Suzhou
NCT03919240 on ClinicalTrials.gov ↗
Active Phase 3
Solid Tumors
Hoffmann-La Roche · started 2015-02-02
Beijing · Changchun · Chengdu · Hangzhou · Harbin · Nanjing
NCT02320435 on ClinicalTrials.gov ↗
Recruiting Phase 2/Phase 3
Primary Central Nervous System Lymphoma
Navy General Hospital, Beijing · started 2010-09
Beijing
NCT02657785 on ClinicalTrials.gov ↗
No trials match your search.

Browse by location

Beijing · 51 Shanghai · 34 Guangzhou · 28 Chengdu · 15 Nanjing · 14 Changsha · 12 Wuhan · 11 Chongqing · 10 Hangzhou · 10 Tianjin · 9 Fuzhou · 8 Hefei · 7

Browse by condition

Breast Cancer · 6 Non-small Cell Lung Cancer · 4 Peripheral T Cell Lymphoma · 3 Solid Tumor · 2 Heart Failure · 2 Esophageal Squamous Cell Carcinoma · 2 Ischemic Stroke · 2 Transient Ischemic Attack (TIA) · 2 Cardiac Arrest · 2 Hypertriglyceridemia · 2 Ulcerative Colitis · 2 Primary Aldosteronism · 2 Chronic Lymphocytic Leukemia · 2 Small Lymphocytic Lymphoma · 2 Hepatocellular Carcinoma · 2 Prostate Cancer · 2
Cite this page

Priya Life Science (2026). Clinical Trials in China Tracker. Available at: https://priyalifescience.com/clinical-trials-china (Accessed: 5 September 2026).

Source: ClinicalTrials.gov, U.S. National Library of Medicine — studies listing at least one Chinese site, refreshed daily. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician.